Paysign (PAYS): תחזית צמיחת רווח נקי למניה לשנה הבאה

The development of AI-driven anti-fraud systems and new wallets supports a positive trend for Paysign, Inc. (PAYS), as confirmed by the 12-month expected EPS growth chart, where the current value is 13.70. Business stability is ensured by a narrow specialization in cards for the pharmaceutical sector, while profits rely on plasma donor activity and the number of partner biomaterial collection centers.

Asset quality is determined by a business's ability to generate excess profit in the future. This indicator measures the dynamics of expected earnings per share, where stagnant values signal that the market is searching for a fair control premium. By analyzing the trend of consensus earnings per share estimates on the GURU.Markets platform, an investor identifies hidden value drivers. For Paysign, Inc. (PAYS), this is the growth of card transactions within the expanding US plasma collection center sector.